|
Nath Bio-Genes (India) Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
285.57 Cr.
|
P/BV
|
0.45
|
Book Value (Rs.)
|
336.91
|
|
52 Week High/Low (Rs.)
|
239/138
|
FV/ML
|
10/1
|
P/E(X)
|
7.40
|
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
20.31
|
Div Yield (%)
|
1.33
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 19.85 | 19.52 | 18.43 | -35.55 | 7.34 |
| Diluted EPS (Rs.) | 19.85 | 19.52 | 18.43 | -35.55 | 7.34 |
| Cash EPS (Rs.) | 22.32 | 22.56 | 20.01 | -33.84 | 10.16 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 339.08 | 320.94 | 301.60 | 285.16 | 35.91 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 339.08 | 320.94 | 301.60 | 285.16 | 35.91 |
| Revenue From Operations / Share (Rs.) | 192.02 | 175.03 | 158.58 | 146.47 | 86.04 |
| PBDIT / Share (Rs.) | 28.60 | 26.57 | 25.94 | 20.54 | 12.80 |
| PBIT / Share (Rs.) | 26.59 | 24.85 | 24.36 | 18.92 | 9.98 |
| PBT / Share (Rs.) | 21.36 | 21.87 | 19.03 | -33.38 | 7.68 |
| Net Profit / Share (Rs.) | 20.31 | 20.85 | 18.42 | -35.46 | 7.34 |
| NP After MI And SOA / Share (Rs.) | 20.31 | 20.85 | 18.42 | -35.46 | 7.34 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 14.89 | 15.17 | 16.35 | 14.02 | 14.87 |
| PBIT Margin (%) | 13.84 | 14.19 | 15.35 | 12.91 | 11.59 |
| PBT Margin (%) | 11.12 | 12.49 | 12.00 | -22.78 | 8.92 |
| Net Profit Margin (%) | 10.57 | 11.91 | 11.61 | -24.20 | 8.52 |
| NP After MI And SOA Margin (%) | 10.57 | 11.91 | 11.61 | -24.20 | 8.52 |
| Return on Networth / Equity (%) | 5.99 | 6.49 | 6.10 | -12.43 | 20.43 |
| Return on Capital Employeed (%) | 7.64 | 7.64 | 8.03 | 6.59 | 26.54 |
| Return On Assets (%) | 3.76 | 4.50 | 4.41 | -9.11 | 7.42 |
| Long Term Debt / Equity (X) | 0.02 | 0.01 | 0.00 | 0.00 | 0.02 |
| Total Debt / Equity (X) | 0.19 | 0.18 | 0.18 | 0.17 | 0.31 |
| Asset Turnover Ratio (%) | 0.38 | 0.39 | 0.39 | 0.00 | 1.05 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.89 | 2.18 | 2.41 | 2.41 | 1.22 |
| Quick Ratio (X) | 0.96 | 1.30 | 1.45 | 1.27 | 0.43 |
| Inventory Turnover Ratio (X) | 1.28 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 9.84 | 9.59 | 10.85 | -5.64 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 8.96 | 8.86 | 9.99 | -5.91 | 0.00 |
| Earning Retention Ratio (%) | 90.16 | 90.41 | 89.15 | 105.64 | 0.00 |
| Cash Earning Retention Ratio (%) | 91.04 | 91.14 | 90.01 | 105.91 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 5.18 | 5.54 | 4.87 | 3.68 | 5.58 |
| Interest Coverage Ratio (Post Tax) (%) | 4.63 | 4.97 | 4.46 | 3.02 | 4.20 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 310.77 | 363.13 | 336.48 | 494.22 | 0.00 |
| EV / Net Operating Revenue (X) | 0.85 | 1.09 | 1.12 | 1.78 | 0.00 |
| EV / EBITDA (X) | 5.72 | 7.19 | 6.83 | 12.66 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.75 | 0.99 | 0.89 | 1.46 | 0.00 |
| Retention Ratios (%) | 90.15 | 90.40 | 89.14 | 105.64 | 0.00 |
| Price / BV (X) | 0.43 | 0.54 | 0.46 | 0.74 | 0.00 |
| Price / Net Operating Revenue (X) | 0.75 | 0.99 | 0.89 | 1.46 | 0.00 |
| EarningsYield | 0.13 | 0.11 | 0.13 | -0.16 | 0.00 |
